Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 18 studies | 24% ± 6% | |
oligodendrocyte | 13 studies | 35% ± 15% | |
memory B cell | 11 studies | 20% ± 3% | |
microglial cell | 5 studies | 26% ± 9% | |
macrophage | 4 studies | 21% ± 4% | |
classical monocyte | 3 studies | 27% ± 8% | |
endothelial cell | 3 studies | 18% ± 1% | |
dendritic cell | 3 studies | 28% ± 12% | |
astrocyte | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2403.37 | 653 / 653 | 100% | 19.01 | 603 / 605 |
kidney | 100% | 2172.20 | 89 / 89 | 99% | 13.90 | 895 / 901 |
prostate | 100% | 2305.59 | 245 / 245 | 99% | 21.03 | 497 / 502 |
uterus | 100% | 1320.39 | 170 / 170 | 99% | 12.57 | 453 / 459 |
brain | 99% | 1524.14 | 2605 / 2642 | 100% | 20.77 | 705 / 705 |
intestine | 100% | 2386.92 | 966 / 966 | 98% | 11.89 | 519 / 527 |
esophagus | 100% | 1891.17 | 1444 / 1445 | 98% | 9.42 | 179 / 183 |
lung | 100% | 1795.16 | 577 / 578 | 97% | 10.14 | 1116 / 1155 |
stomach | 98% | 1132.36 | 353 / 359 | 97% | 11.56 | 277 / 286 |
breast | 100% | 1543.07 | 459 / 459 | 94% | 8.83 | 1047 / 1118 |
bladder | 100% | 1874.29 | 21 / 21 | 89% | 10.28 | 448 / 504 |
pancreas | 85% | 606.55 | 279 / 328 | 98% | 17.56 | 175 / 178 |
adrenal gland | 97% | 945.05 | 251 / 258 | 82% | 12.24 | 189 / 230 |
ovary | 77% | 538.98 | 138 / 180 | 89% | 7.98 | 383 / 430 |
skin | 73% | 1128.71 | 1321 / 1809 | 92% | 9.62 | 432 / 472 |
liver | 78% | 469.61 | 176 / 226 | 79% | 6.97 | 321 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 74.94 | 29 / 29 |
muscle | 100% | 5002.62 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4816.58 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 14.10 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.94 | 1 / 1 |
peripheral blood | 100% | 7178.08 | 928 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1652.01 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1388.75 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 1951.08 | 856 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 50% | 2.63 | 40 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007040 | Biological process | lysosome organization |
GO_0001892 | Biological process | embryonic placenta development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0009267 | Biological process | cellular response to starvation |
GO_0006959 | Biological process | humoral immune response |
GO_0002250 | Biological process | adaptive immune response |
GO_0140367 | Biological process | antibacterial innate immune response |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0032418 | Biological process | lysosome localization |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0006914 | Biological process | autophagy |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TFEB |
Protein name | Transcription factor EB (Class E basic helix-loop-helix protein 35) (bHLHe35) TFEB transcription factor (Transcription factor EB) Transcription factor EB |
Synonyms | AlphaTFEB BHLHE35 |
Description | FUNCTION: Transcription factor that acts as a master regulator of lysosomal biogenesis, autophagy, lysosomal exocytosis, lipid catabolism, energy metabolism and immune response . Specifically recognizes and binds E-box sequences (5'-CANNTG-3'); efficient DNA-binding requires dimerization with itself or with another MiT/TFE family member such as TFE3 or MITF . Involved in the cellular response to amino acid availability by acting downstream of MTOR: in the presence of nutrients, TFEB phosphorylation by MTOR promotes its cytosolic retention and subsequent inactivation . Upon starvation or lysosomal stress, inhibition of MTOR induces TFEB dephosphorylation, resulting in nuclear localization and transcription factor activity . Specifically recognizes and binds the CLEAR-box sequence (5'-GTCACGTGAC-3') present in the regulatory region of many lysosomal genes, leading to activate their expression, thereby playing a central role in expression of lysosomal genes . Regulates lysosomal positioning in response to nutrient deprivation by promoting the expression of PIP4P1 . Acts as a positive regulator of autophagy by promoting expression of genes involved in autophagy . In association with TFE3, activates the expression of CD40L in T-cells, thereby playing a role in T-cell-dependent antibody responses in activated CD4(+) T-cells and thymus-dependent humoral immunity (By similarity). Specifically recognizes the gamma-E3 box, a subset of E-boxes, present in the heavy-chain immunoglobulin enhancer . Plays a role in the signal transduction processes required for normal vascularization of the placenta (By similarity). Involved in the immune response to infection by the bacteria S.aureus, S.typhimurium or S.enterica: infection promotes itaconate production, leading to alkylation, resulting in nuclear localization and transcription factor activity . Itaconate-mediated alkylation activates TFEB-dependent lysosomal biogenesis, facilitating the bacteria clearance during the antibacterial innate immune response . In association with ACSS2, promotes the expression of genes involved in lysosome biogenesis and both autophagy upon glucose deprivation . . |
Accessions | ENST00000445214.2 [P19484-1] B1AKB2 ENST00000406563 Q709A5 ENST00000343317.11 [P19484-1] B1AKB1 ENST00000420312.6 [P19484-1] ENST00000424495.2 [P19484-1] P19484 ENST00000678831.1 [P19484-1] ENST00000419396.6 [P19484-1] ENST00000403298.9 [P19484-1] ENST00000406563.7 [P19484-2] ENST00000416140.6 [P19484-1] B1AKA9 ENST00000230323.8 [P19484-1] B1AKB5 ENST00000416140 B0QYS6 Q709B0 ENST00000677531.1 [P19484-1] A0A7I2YQR9 Q86WB1 Q709A9 A0A1B0GXL9 ENST00000445214 ENST00000419574.6 [P19484-1] ENST00000358871.6 ENST00000419574 ENST00000419396 ENST00000394283.5 ENST00000373033.6 [P19484-1] ENST00000343317 B0QYS7 B1AKB4 ENST00000678871.1 Q709A8 ENST00000424495 |